Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).
Guideline
Hyperparathyroidism
Parathyroid carcinoma
Parathyroidectomy
Primary hyperparathyroidism
Renal hyperparathyroidism
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
29
03
2021
accepted:
06
04
2021
pubmed:
22
4
2021
medline:
25
9
2021
entrez:
21
4
2021
Statut:
ppublish
Résumé
The purpose of this review is to provide updated recommendations for the surgical management of primary (pHPT) and renal (rHPT) hyperparathyroidism, formulating a new guideline of the German Association of Endocrine Surgeons (CAEK). Evidence-based recommendations for the diagnosis and therapy of pHPT and rHPT were assessed by a multidisciplinary panel using PubMed for a comprehensive literature search together with a structured consensus dialogue (S2k guideline of the Association of the German Scientific Medical Societies, AWMF). During the last 20 years, a variety of new preoperative localization procedures, such as sestamibi-SPECT, 4D-CT, and various PET/CT procedures, were established for pHPT. High-resolution imaging, together with intraoperative parathyroid hormone (IOPTH) measurement, enabled focused or minimally invasive surgery to become the most favored surgical technique. Patients with pHPT and nonlocalizing imaging have a higher risk of multiglandular disease. Surgical therapy provides very high cure rates, with a clear relation to the surgeon's experience in parathyroid procedures. Reoperative parathyroidectomy, children with pHPT or familial forms, and parathyroid carcinoma are addressed and require special surgical expertise. A multidisciplinary team of experienced nephrologists, transplant, and endocrine surgeons should assess the diagnosis and treatment of renal HPT. Surgery is the only curative treatment for pHPT and should be considered for all patients with pHPT. For rHPT, a more selective approach is required, and parathyroidectomy is indicated only when conservative treatment options fail. In parathyroid carcinoma, the adequacy of local resection influences local disease control.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
The purpose of this review is to provide updated recommendations for the surgical management of primary (pHPT) and renal (rHPT) hyperparathyroidism, formulating a new guideline of the German Association of Endocrine Surgeons (CAEK).
METHODS
METHODS
Evidence-based recommendations for the diagnosis and therapy of pHPT and rHPT were assessed by a multidisciplinary panel using PubMed for a comprehensive literature search together with a structured consensus dialogue (S2k guideline of the Association of the German Scientific Medical Societies, AWMF).
RESULTS
RESULTS
During the last 20 years, a variety of new preoperative localization procedures, such as sestamibi-SPECT, 4D-CT, and various PET/CT procedures, were established for pHPT. High-resolution imaging, together with intraoperative parathyroid hormone (IOPTH) measurement, enabled focused or minimally invasive surgery to become the most favored surgical technique. Patients with pHPT and nonlocalizing imaging have a higher risk of multiglandular disease. Surgical therapy provides very high cure rates, with a clear relation to the surgeon's experience in parathyroid procedures. Reoperative parathyroidectomy, children with pHPT or familial forms, and parathyroid carcinoma are addressed and require special surgical expertise. A multidisciplinary team of experienced nephrologists, transplant, and endocrine surgeons should assess the diagnosis and treatment of renal HPT.
CONCLUSION
CONCLUSIONS
Surgery is the only curative treatment for pHPT and should be considered for all patients with pHPT. For rHPT, a more selective approach is required, and parathyroidectomy is indicated only when conservative treatment options fail. In parathyroid carcinoma, the adequacy of local resection influences local disease control.
Identifiants
pubmed: 33880642
doi: 10.1007/s00423-021-02173-1
pii: 10.1007/s00423-021-02173-1
doi:
Substances chimiques
Parathyroid Hormone
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
571-585Références
Nilsson IL (2019) Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med 285:149–164
pubmed: 30289185
Chirurgische Therapie des primären Hyperparathyreoidismus. Mitteilungen der Deutschen Gesellschaft für Chirurgie G86, Heft 04/1999
Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosén T, Nordenström J, Jansson S, Hellström M, Bollerslev J, SIPH Study Group (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild hyperparathyroidism. J Clin Endocrinol Metab 100:1359–1367
pubmed: 25636048
Roman SA, Sosa JA, Pietrzak RH, Snyder PJ, Thomas DC, Udelsman R, Mayes L (2011) The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 253:131–137
pubmed: 21233611
Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA (2011) Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab 96:E1737–E1745
pubmed: 21917870
Weber T, Eberle J, Messelhäuser U, Schiffmann L, Nies C, Schabram J, Zielke A, Holzer K, Rottler E, Henne-Bruns D, Keller M, von Wietersheim J (2013) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg 148:109–115
pubmed: 23560281
Yu N, Donnan PT, Flynn RW, Murphy MJ, Smith D, Rudman A, Leese GP (2010) Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf.) 73:30–34
Yu N, Donnan PT, Leese GP (2011) A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol 72:169–176
Prommegger R, Wimmer G, Profanter C, Sauper T, Sieb M, Kovacs P, Bale R, Putzer D, Gabriel M, Margreiter R (2009) Virtual neck exploration: a new method for localizing abnormal parathyroid glands. Ann Surg 250:761–765
pubmed: 19806053
Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19:577–583
pubmed: 21710322
Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF et al (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:124–128
Beheshti M, Hehenwarter L, Paymani Z, Rendl G, Imamovic L, Rettenbacher R, Tsybrovskyy O, Langsteger W, Pirich C (2018) 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTC-MIBI or 99mTC-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Imaging 45:1762–1771
Rajaei MH, Bentz AM, Schneider DF, Sippel RS, Chen H, Oltman SC (2015) Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol 22:454–459
pubmed: 25192677
Kazaure HS, Thomas S, Scheri RP, Stang MT, Roman SA, Sosa JA (2019) The devil is in the details: assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. Surgery 165:242–249
pubmed: 30327186
Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246:976–980
pubmed: 18043099
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh Q-Y, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solórzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surgery 151:959–968
pubmed: 27532368
KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD) (2017). Kidney Int Suppl 7:1–59
Boehm BO, Rosinger S, Belyi D, Dietrich JW (2011) The parathyroid as a target for radiation damage. N Engl J Med 365:676–678
pubmed: 21848480
Lehmann SW, Lee J (2013) Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: what do we know? J Affect Disord 146:151–157
pubmed: 22985484
Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: Is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908–911
pubmed: 18716127
Tay YD, Liu M, Bandeira L, Bucovsky M, Lee JA, Silverberg SJ, Walker MD (2018) Occult urolithiasis I asymptomatic primary hyperparathyroidism. Endocr Res 43:106–115
pubmed: 29400579
pmcid: 6042842
Reid LJ, Muthukrishnan B, Patel D, Seckl JR, Gibb FW (2019) Predictors of nephrolithiasis, osteoporosis, and mortality in primary hyperparathyroidism. J Clin Endocrinol Metab 104:3692–3700
pubmed: 30916764
Castellano E, Attanasio R, Boriano A, Pellegrino M, Garino F, Gianotti L, Borretta G (2017) Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J Clin Endocrinol Metab 102:4148–4152
pubmed: 28938410
Rigg J, Gilbertson E, Barrett HL, Britten FL, Lust K (2019) Primary hyperparathyroidism in pregnancy: maternofetal outcomes in a quaternary referral obstetric hospital, 2000 through 2005. J Clin Endocrinol Metab 104:721–729
pubmed: 30247615
Yang J, Dong MJ, Chen F (2019) A rare lethal case of severe acute necrotisizing pancreatitis due to a parathyroid adenoma in a third-trimester pregnant women. BMC Endocr Disord 19:82
pubmed: 31357974
pmcid: 6664735
Mollerup CL, Verstergaard P, Frokjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M (2002) Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow-up study. BMJ 325:807
pubmed: 12376441
pmcid: 128947
VanderWalde LH, Lui IL, Haigh PI (2009) Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World J Surg 33:406–411
pubmed: 18763015
Kearns AE, Espiritu RP, Vickers Douglass K, Thapa P, Wermers RA (2019) Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism. Clin Endocrinol 91:464–470
Bannani S, Christou N, Guérin C, Hamy A, Sebag F, Mathonnet M, Guillot P, Caillard C, Blanchard C, Mirallié E (2018) Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcemic primary hyperparathyroidism. Br J Surg 105:223–229
pubmed: 29405278
Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N (2014) Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 7:732–739
pubmed: 25104043
McMahon DJ, Carrelli A, Plameri N, Zahng C, DiTullo M, Silverberg SJ, Waker MD (2015) Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 100:4399–4407
pubmed: 26445115
pmcid: 4667168
Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764
pubmed: 19575214
Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 394:851–860
Bergenfelz AO, Jansson SK, Wallin GK, Martensson HG, Rasmussen L, Eriksson HL, Reihnér EI (2009) Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients. Langenbecks Arch Surg 394:851–860
pubmed: 19618204
Thier M, Daudi S, Bergenfelz A, Almquist M (2018) Predictors of multiglandular disease in primary hyperparathyroidism. Langenbecks Arch Surg 403:103–109
pubmed: 29294178
pmcid: 5805794
Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh QY, Clark OH, Kebebew E (2010) Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 145:578–581
pubmed: 20566979
Huber GF, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann PA, von Schulthess GK (2018) Benefit of 18F-fluorocholidine PET imaging in parathyroid surgery. Eur J Radiol 28:2700–2707
Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Hellman P, Akerstrom G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781
pubmed: 18335276
Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD (2017) Comparative effectiveness of ultrasonography, 99mTc-sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med 42:e491–e497
pubmed: 28902729
Reidel MA, Schilling T, Graf S, Hinz U, Nawroth P, Büchler MW, Weber T (2006) Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism. Surgery 140:907–913
pubmed: 17188137
Ito F, Sippel R, Lederman J, Chen H (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245:959–963
pubmed: 17522522
pmcid: 1876969
Starker LF, Bjorklund P, Theoharis C, Long WD 3rd, Carling T, Udelsman R (2011) Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg 35:331–335
pubmed: 21042912
Uruno T, Masaki C, Suzuki A, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K (2015) Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial. World J Surg 39:1282–1287
pubmed: 25566977
Riss P, Krall C, Scheuba C, Bieglmayer C, Niederle B (2013) Risk factors for “PTH spikes” during surgery for primary hyperparathyroidism. Langenbecks Arch Surg 398:881–886
pubmed: 23828733
Meyer SK, Zorn M, Frank-Raue K, Büchler MW, Nawroth P, Weber T (2009) Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism. Eur J Endocrinol 160:275–281
pubmed: 19004983
Miller BS, England BG, Nehs M, Burney RE, Doherty GM, Gauger PG (2006) Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of < 100 pg/mL. Surgery 140:883–889
pubmed: 17188134
Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 253:585–591
pubmed: 21183844
Karakas E, Schneider R, Rothmund M, Bartsch DK, Schlosser K (2014) Initial surgery for benign primary hyperparathyroidism: an analysis of 1,300 patients in a teaching hospital. World J Surg 38:2011–2018
pubmed: 24696057
Yabuta T, Tsushima Y, Masuoka H, Tomoda C, Fukushima M, Kihara M, Inoue H, Higashiyama T, Takamura Y, Ito Y, Kobayashi K, Miya A, Miyauchi A (2011) Ultrasononic features of intrathyroidal parathyroid adenoma causing primary hyperparathyroidism. Endocr J 58:989–994
pubmed: 21908928
Mazeh H, Kouniavsky G, Schneider DF, Makris KI, Sippel RS, Dackiw APB et al (2012) Intrathyroidal parathyroid glands: small, but mighty (a Napoleon phenomenon). Surgery 152:1192–1200
James BC, Kaplan EL, Grogan RH, Angelos P (2015) What´s in a name? Providing clarity in the definition of minimally invasive parathyroidectomy. World J Surg 39:975–980
pubmed: 25446489
Grant CS, Thompson G, Farley D, van Heerden J (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo clinic experience. Arch Surg 140:472–478
pubmed: 15897443
Lew JI, Rivera M, Irvin GL 3rd, Solorzano CC (2010) Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg 145:628–633
pubmed: 20644124
Venkat R, Kouniavsky G, Tufano RP, Schneider EB, Dackiw AP, Zeiger M (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60
pubmed: 22089919
Miccoli P, Berti P, Materazzi G, Massi M, Picone A, Minuto MN (2004) Results of video-assisted parathyroidectomy: single institution’s six-year experience. World J Surg 28:1216–1218
pubmed: 15517483
Sasanakietkul T, Jitpratoom P, Anuwong A (2017) Transoral endoscopic parathyroidectomy vestibular approach: a novel scarless parathyroid surgery. Surg Endoc 31:3755–3763
Karakas E, Anuwong A, Ketwong K, Kounnamas A, Schopf S, Klein G (2018) Transoral thyroid and parathyroid surgery: implementation and evaluation of the transoral endoscopic technique via the vestibular approach (TOETVA). Chirurg 89:537–544
pubmed: 29637242
Hurtado-Lopez LM, Gutiérrez-Román SH, Basurto-Kuba E, Luna-Ortiz K (2019) Endoscopic transoral parathyroidectomy: initial experience. Head Neck 41:3334–3337
pubmed: 31157933
Landry CS, Grubbs EG, Morris GS, Turner NS, Holsinger FC, Lee JE, Perrier ND (2011) Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery 149:549–555
pubmed: 20947113
He Q, Zhu J, Zhuang D, Fan Z (2015) Robotic total parathyroidectomy by the axillo-bilateral-breast approach for secondary hyperparathyroidism: a feasibility study. J Laparoendosc Adv Surg Tech 25:311–313
VanSlyke S, Van Den Heede K, Magamadov K, Brusselaers N, Vermeersch H (2019) Robotic-assisted parathyroidectomy through lateral cervical approach: first results in Belgium. Acta Chir Belg 22:1–6
Riss P, Kammer M, Selberherr A, Scheuba C, Niederle B (2015) Morbidity associated with concomitant thyroid surgery in patients with primary hyperparathyroidism. Ann Surg Oncol 22:2707–2713
pubmed: 25480411
Kiernan CM, Schlegel C, Kavalukas S, Isom C, Peters MF, Solozano CC (2016) Does concomitant thyroidectomy increase risks of parathyroidectomy? J Surg Res 203:34–39
pubmed: 27338532
Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, Goretzki PE et al (2018) Aktualisierung der S2k-Leitlinie: operative Therapie benigner Schiddrüsenerkrankungen. Chirurg 89:699–709
pubmed: 29876616
Kaderli RM, Riss P, Geroldinger A, Selberherr A, Scheuba C, Niederle B (2018) Primary hyperparathyroidism: dynamic postoperative metabolic changes. Clin Endocrinol 88:129–138
Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551
pubmed: 12409657
pmcid: 1422609
Kaderli RM, Riss P, Dunkler D, Pietschmann P, Selberherr A, Scheuba C, Niederle B (2018) The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism. Eur J Endocrinol 178:1–9
pubmed: 28877925
Witteveen JE, van Thiel S, Romijn JA, Hamdy NAT (2013) Hungry bone syndrome: Still a challenge in the postoperative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 168:45–53
Hermann M (2010) Primärer Hyperparathyreoidismus: postoperative, normokalzämische Hyperparathyrinämie nach kurativer Parathyreoidektomie. Chirurg 81:447–453
pubmed: 19468699
Lou I, Balantine C, Clarkson S, Schneider DF, Sippel RS, Chen H (2017) How long should we follow patients after apparently curative parathyroidectomy? Surgery 161:54–61
pubmed: 27863779
Prescott JD, Udelsman R (2009) Remedial operation for primary hyperparathyroidism. World J Surg 33:2324–2334
pubmed: 19290572
Karakas E, Müller HH, Schlosshauer T, Rothmund M, Bartsch DK (2013) Reoperations for primary hyperparathyroidism-improvement of outcome over two decades. Langenbecks Arch Surg 398:99–106
pubmed: 23001050
Iacobone M, Scerrino G, Palazzo FF (2019) Parathyroid surgery: an evidence-based volume-outcome analysis: European Society of Endocrine Surgeons (ESES) positional statement. Langenbecks Arch Surg 404:919–927
pubmed: 31595330
Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel R, Chen H (2015) How well does renal transplantation cure hyperparathyroidism? Ann Surg 262:653–659
pubmed: 26366545
pmcid: 4576689
Cheng SP, Lee JJ, Liu TP, Yang TL, Chen HH, Wu CJ, Liu CL (2014) Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism. Surgery 155:320–328
pubmed: 24035616
Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC, on behalf of the ARO Investigators (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26:1948–1955
pubmed: 20466670
Kim WW, Rhee Y, Kim BS, Kim K, Lee CR, Kang S-W, Lee J, Jeong JJ, Nam KH, Chung WY (2019) Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism. Endocr J 66:881–889
pubmed: 31189770
Finnerty BM, Chan TW, Jones G, Khader T, Moore M, Gray KD, Beninato T, Watkins AC, Zarnegar R, Fahey TJ III (2019) Parathyroidectomy versus cincalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery 165:129–134
pubmed: 30415867
National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201
Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, Polo C, Revuelta I, Francos J, Torras J, García-Barrasa A, Bestard O, Grinyó JM (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27:2487–2494
pubmed: 26647424
De la Rosa A, Jimeno J, Membrilla E, Sancho JJ, Pereira JA, Sitges-Serra A (2008) Usefulness of preoperative Tc-mibi parathyroid scintigraphy in secondary hyperparathyroidism. Langenbecks Arch Surg 393:21–24
pubmed: 17294211
Lorenz K, Bartsch DK, Sancho JJ, Guigard S, Triponez F (2015) Surgical management of secondary hyperparathyroidism in chronic kidney disease-a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg 400:907–927
pubmed: 26429790
Weber T, Zeier M, Hinz U, Schilling T, Büchler MW (2005) Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 29:1176–1179
pubmed: 16132402
Freriks K, Hermus ARMM, de Sévaux RGL, Bonenkamp HJ, Biert J, Heijer d M et al (2010) Usefulness of intraoperative parathyroid hormone measurement in patients with renal hyperparathyroidism. Head Neck 3:1328–1335
Chen J, Jia X, Kong X, Wang Z, Cui M, Xu D (2017) Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: a systematic review and meta-analysis. Nephrology 22:388–396
pubmed: 27085089
Yuan Q, Liao Y, Zhou R, Liu J, Tang J, Wu G (2019) Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis. Langenbecks Arch Surg 404:669–679
pubmed: 31377854
Schlosser K, Bartsch DK, Diener MK, Seiler CM, Bruckner T, Nies C, Meyer M, Neudecker J, Goretzki PE, Glockzin G, Konopke R, Rothmund M (2016) Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism: results of a nonconfirmatory multicenter prospective randomized controlled pilot trial. Ann Surg 264:745–753
pubmed: 27741007
Schneider R, Waldmann J, Ramaswamy A, Fernández ED, Bartsch DK, Schlosser K (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35:1260–1265
pubmed: 21479685
Schneider R, Ramaswamy A, Slater EP, Bartsch DK, Schlosser K (2012) Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense? Surgery 36:2598–2604
Cohen MS, Dilley WG, Wells SA Jr, Moley JF, Doherty GM, Sicard GA, Skinner MA, Norton JA, DeBenedetti MK, Lairmore TC (2005) Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis. Surgery 138:1033–1040
pubmed: 16360388
Goldfarb M, Gondek SS, Lim SM, Farra JC, Nose V, Lew JI (2012) Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 36:1314–1319
pubmed: 22399154
Ho LY, Wong PN, Sin HK, Wong YY, Lo KC, Chan SF, Lo MW, Lo KY, Mak SK, Wong AKM (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18:12
pubmed: 28073343
pmcid: 5223390
Van der Plas WY, Engelsman AF, Özyilmaz A, van der Horst-Schrivers AN, Meijer K, van Dam GM et al (2017) Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism. Ann Surg Oncol 24:15–22
pubmed: 27459979
Pattou FN, Pellissier LC, Noel C, Wambergue F, Huglo DG, Proye CA (2000) Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 24:1330–1334
pubmed: 11038202
Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, Röher HD (2003) Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 387:348–354
pubmed: 12536330
Waldmann J, López CL, Langer P, Rothmund M, Bartsch DK (2010) Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg 97:1528–1534
pubmed: 20629112
Schreinemakers JMJ, Pieterman CRC, Scholten A, Vriens MR, Valk GD, Rinkes IHMB (2011) The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg 35:1993–2005
pubmed: 21713580
Pieterman CRC, van Hulsteijn LT, Heijer d M, van der Luijt RB, Bonenkamp JJ, Hermus ARMM et al (2012) Primary hyperparathyroidism in MEN1 patients: a cohort study with long-term follow-up on preferred surgical procedure and the relation with genotype. Ann Surg 255:1171–1178
pubmed: 22470073
Nilubol N, Weinstein LS, Simonds WF, Jensen RT, Marx SJ, Kebebew E (2016) Limited parathyroidectomy in multiple endocrine neoplasia type 1-asscoiated primary hyperparathyroidism: a setup for failure. Ann Surg Oncol 23:416–423
pubmed: 26542588
Iacobone M, Carnaille B, Palazzo FF, Vriens M (2015) Hereditary hyperparathyroidism-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 400:867–886
pubmed: 26450137
Marx JM, Lourenco DM (2017) Familial hyperparathyroidism-disorders of growth and secretion in hormones-secretory tissue. Horm Metab Res 49:805–815
pubmed: 29136674
Frank-Raue K, Leidig-Bruckner G, Haag C, Schulze E, Lorenz A, Schmitz-Winnenthal H, Raue F (2011) Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol 75:50–55
Rampp RD, Mancilla EE, Adzick NS, Levine MA, Kelz RR, Fraker DL, Iyer P, Lindeman BM, Mejia VA, Chen H, Wachtel H (2020) Single gland, ectopic localization: adenomas are common causes of primary hyperparathyroidism in children and adolescents. World J Surg 44:1518–1525
pubmed: 31900569
pmcid: 7124981
Pashtan I, Grogan RH, Kaplan SP, Devon K, Angelos P, Lui D, Kaplan EI (2013) Primary hyperparathyroidism in adolescents: the same but different. Pediatr Surg Int 29:275–279
pubmed: 23184264
Langusch CC, Norlen O, Titmuss A, Donoghue K, Holland AJ, Shun A, Delbridge L (2015) Focused image-guided parathyroidectomy in the current management of primary hyperparathyroidism. Arch Dis Child 100:924–927
pubmed: 25897038
Nicholson KJ, McCoy KL, Witchel SF, Stang MT, Carty SE, Yip L (2016) Comparative characteristics of primary hyperparathyroidism in pediatric and young adult patients. Surgery 160:1008–1016
pubmed: 27506863
Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, Roman SA (2008) Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab 93:3058–3065
pubmed: 18522977
Lenschow C, Schrägle S, Kircher S, Lorenz K, Machens A, Dralle H et al (2020) Clinical presentation, treatment and outcome of parathyroid carcinoma: results of the NEKAR retrospective international multicenter study. Ann Surg in press; EMID:b206508b1c669067
Asari EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND et al (2015) Parathyroid carcinoma: an update on treatment course and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol 22:3390–3995